Literature DB >> 27717855

Isothermal titration calorimetry for drug design: Precision of the enthalpy and binding constant measurements and comparison of the instruments.

Vaida Linkuvienė1, Georg Krainer2, Wen-Yih Chen3, Daumantas Matulis4.   

Abstract

Isothermal titration calorimetry (ITC) is one of the most robust label- and immobilization-free techniques used to measure protein - small molecule interactions in drug design for the simultaneous determination of the binding affinity (ΔG) and the enthalpy (ΔH), both of which are important parameters for structure-thermodynamics correlations. It is important to evaluate the precision of the method and of various ITC instrument models by performing a single well-characterized reaction. The binding between carbonic anhydrase II and acetazolamide was measured by four ITC instruments - PEAQ-ITC, iTC200, VP-ITC, and MCS-ITC and the standard deviation of ΔG and ΔH was determined. Furthermore, the limit of an approach to reduce the protein concentration was studied for a high-affinity reaction (Kd = 0.3 nM), too tight to be measured by direct (non-displacement) ITC. Chemical validation of the enthalpy measurements is discussed.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acetazolamide; Calorimeter; Carbonic anhydrase; Enthalpy; Isothermal titration calorimetry (ITC); Nitpic and Sedphat; Protein – ligand binding

Mesh:

Substances:

Year:  2016        PMID: 27717855     DOI: 10.1016/j.ab.2016.10.005

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  7 in total

1.  Targeting Mcl-1 enhances DNA replication stress sensitivity to cancer therapy.

Authors:  Guo Chen; Andrew T Magis; Ke Xu; Dongkyoo Park; David S Yu; Taofeek K Owonikoko; Gabriel L Sica; Sarah W Satola; Suresh S Ramalingam; Walter J Curran; Paul W Doetsch; Xingming Deng
Journal:  J Clin Invest       Date:  2017-12-11       Impact factor: 14.808

2.  Intrinsically disordered chromatin protein NUPR1 binds to the C-terminal region of Polycomb RING1B.

Authors:  Patricia Santofimia-Castaño; Bruno Rizzuti; Ángel L Pey; Philippe Soubeyran; Miguel Vidal; Raúl Urrutia; Juan L Iovanna; José L Neira
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-18       Impact factor: 11.205

3.  A rapid solution-based method for determining the affinity of heroin hapten-induced antibodies to heroin, its metabolites, and other opioids.

Authors:  Oscar B Torres; Alexander J Duval; Agnieszka Sulima; Joshua F G Antoline; Arthur E Jacobson; Kenner C Rice; Carl R Alving; Gary R Matyas
Journal:  Anal Bioanal Chem       Date:  2018-04-19       Impact factor: 4.142

4.  Synthesis and biological evaluation of thiazole derivatives as LbSOD inhibitors.

Authors:  Camila C Bitencourt Brito; Hélder Vinicius Carneiro da Silva; Daci José Brondani; Antonio Rodolfo de Faria; Rafael Matos Ximenes; Ivanildo Mangueira da Silva; Julianna F C de Albuquerque; Marcelo Santos Castilho
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

Review 5.  Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase.

Authors:  Alessio Nocentini; Andrea Angeli; Fabrizio Carta; Jean-Yves Winum; Raivis Zalubovskis; Simone Carradori; Clemente Capasso; William A Donald; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

6.  Origin and Formation Mechanism Investigation of Compound Precipitation from the Traditional Chinese Prescription Huang-Lian-Jie-Du-Tang by Isothermal Titration Calorimetry.

Authors:  Hui Wang; Tong Li; Hongjun Xiang; Xinyu Zhang; Kang Fang; Gaorong Wu; Mengmeng Yan; Nannan Xue; Meng Chen; Tianxin Xie; Yuzhong Zhang; Penglong Wang; Haimin Lei
Journal:  Molecules       Date:  2017-09-01       Impact factor: 4.411

7.  Discovery of Small Molecule Bak Activator for Lung Cancer Therapy.

Authors:  Dongkyoo Park; Abu Syed Md Anisuzzaman; Andrew T Magis; Guo Chen; Maohua Xie; Guojing Zhang; Madhusmita Behera; Gabriel L Sica; Suresh S Ramalingam; Taofeek K Owonikoko; Xingming Deng
Journal:  Theranostics       Date:  2021-07-25       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.